[1]
Pal, A., Panja, B., Dutta, T., Subhrojyoti, B., Nath, S. and Bhattacharjee, S. 2017. Ponatinib: a miracle or a disaster in chronic myeloid leukemia. International Journal of Basic & Clinical Pharmacology. 3, 6 (Jan. 2017), 933–936.